MDA.WAR MedApp S.A

Healthcare Software Warsaw Stock Exchange
0.1700 PLN
Close of Oct 29, 2026
0.0800 0.3500
Market cap
PLN 42.5M
P/E
-
P/B
2.57x
ROE
18.9%
Dividend yield
-
Fundamental score
1.4/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is MDA.WAR undervalued?

Graham number

The Graham number of MedApp S.A cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

MedApp S.A fundamental analysis

7 of 22 checks passed

ROE 1/2

Moderate return on equity (18.9%), between 10% and 20%.

ROA 1/1

Return on assets (9.3%) is above the industry median (2.5%).

Profit Consistency 0/2

Not profitable for at least 3 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share did not grow over the past 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 0/1

Last year's EPS growth (-266.3%) is below the industry median (-16.9%).

Revenue Growth 0/2

Revenue shrank 17.2% a year over the past 3 years.

Short-term Liquidity 0/1

Current assets do not cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (0.4%), 40% or less.

Debt Trend 0/1

Debt to equity history is shorter than 5 years.

Debt Coverage 1/1

Operating cash flow covers 20% of total debt.

Interest Coverage 1/1

EBIT is 109.2x against interest expense, well covered.

PE vs Market 0/1

PE is negative or not available.

PE vs Industry 0/1

PE is negative or not available.

PBV 1/1

Price to book (2.6x) is below the industry median (2.8x).

Graham Number 0/1

Graham number needs positive earnings and book value.

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

MedApp S.A stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About MedApp S.A

MedApp S.A. engages in the development of solutions to support imaging diagnostics and digital medicine in Poland, rest of the European Union, and internationally. The company offers CarnaLife Holo, a technology for 3D visualization of imaged medical data which supports the planning and performance of medical procedures. HoloComm, an innovative solution for easy and convenient work on files in 3D. The company was formerly known as Yellow Hat S.A. and changed its name to MedA…

Full company profile